My Chinese medicine exports in the first half of the year were 1.111 billion U.S. dollars

Chinese medicine is mainly originated in China and is a traditional Chinese medicine-specific medicine. According to the processing technology, it can be divided into traditional Chinese medicine and traditional Chinese medicine. In addition to botanicals, animal medicines such as snake gall, five-step snakes, etc.; shells such as pearls, jellyfish shells; minerals with keels, magnets, etc. are also used to treat diseases of traditional Chinese medicine. Chinese medicine is extensive and profound. In recent years, it has received more and more love from the people of all countries in the world. In the first half of this year, China’s imports and exports of Chinese medicine products increased again, reaching US$1.438 billion. This article briefly introduces the overseas sales of Chinese medicines in China.

In the first half of this year, under the continuous influence of the quantitative easing policies of developed countries such as the United States and Japan, global inflationary pressures have further increased, but the world economy as a whole has continued its recovery trend last year. China's pharmaceutical foreign trade has also accelerated its pace of growth. Driven by this, in the first half of the year, the import and export volume of Chinese medicines in China increased by 41.43% year-on-year to 1.438 billion U.S. dollars. Among them, exports amounted to $1.111 billion, an increase of 42.95% year-on-year; import value was $326 million, an increase of 36.5% year-on-year. Foreign trade in Chinese medicines continued to maintain a steady growth. It is expected that the exports of Chinese medicine will continue to increase in the second half of the year, but the growth rate will slow down.

Exports: a general increase in the amount <br> highlights: rapid growth in Europe and America

In the first half of the year, imports and exports of various Chinese medicines generally increased, with the export volumes exceeding US$100 million in January and March. Among the export varieties, plant extracts are still the main exporters, while exports of health products have the largest increase. Among them, the export volume of plant extracts was 525 million U.S. dollars, an increase of 47.68% year-on-year, accounting for 47.27% of the total export volume of Chinese medicines, and remained the main force for the export of Chinese medicines; the import amount of extracts was 86,184,400 U.S. dollars, an increase of 27.53% year-on-year, accounting for Chinese medicine 26.39% of total merchandise imports. In the first half of the year, the export value of Chinese herbal medicines and decoction pieces was 374 million U.S. dollars, an increase of 31.33% year-on-year, accounting for 33.7% of the total exports of Chinese herbal medicines. The export volume of Chinese patent medicines was US$113 million, an increase of 23.36% year-on-year; the import value was US$101 million, a year-on-year decrease of 8.98%. The export value of health products was 98,348,800 U.S. dollars, an increase of 119.4% year-on-year; the import value was 69.536 million U.S. dollars, an increase of 122.15% year-on-year.

In the export market, China’s traditional Chinese medicine exports are dominated by traditional markets, while the European and American natural drug markets are increasingly prosperous. Among them, Japan, Hong Kong, and the United States are still the main export markets for traditional Chinese medicines. In the first half of the year, their export growth exceeded 30%. The export volume of these three markets accounted for 43.51% of the total exports of Chinese medicines.

The rapid growth of the European and American markets has become a major highlight of Chinese medicine exports. In recent years, the market for natural medicines in Europe and the United States has become increasingly prosperous, and consumption has been expanding year by year. In the first half of the year, China’s exports of Chinese medicine to European and American markets have grown substantially year-on-year. Although exports of Chinese patent medicines are limited by EU directives, due to the rapid growth of exports of health products and extracts, the year-on-year growth rate of exports to Europe still reached 77.08%, while the export to North America increased by 55.33%. During the same period, the increase in exports of Chinese medicines to Asian markets was only 28%, which was lower than the average increase in exports of Chinese medicines.

In the first half of the year, there were a total of 2,212 Chinese exporters of traditional Chinese medicine products, an increase of 147 over the same period of 2010. Private enterprises continued to be the main force for exports, accounting for as much as 50.43% of the export value; exports of “triple-funded” enterprises accounted for 29.11%; The export volume of enterprises accounts for only 20.39%. It is worth noting that in the first half of the year, the increase in exports of Chinese medicine by private companies was 69% year-on-year, much higher than that of state-owned and "funded enterprises."

Medicinal materials: Price increase slows
Planting: Prospects continue to improve

From the perspective of export varieties, the exports of Chinese herbal medicines in the first half of the year have their own characteristics in terms of Chinese herbal medicines and plant extracts. The former’s export price growth slowed down, and the latter’s exports entered a transitional period, and the market outlook continues to improve.

Although the export price of Chinese herbal medicines rose by 38% year-on-year in the first half of the year, it only rose by 0.74% month-on-month, and the country’s influence on price control was increasingly apparent. The overall export price of Chinese herbal medicines tends to flatten, and export prices of large medicinal herbs such as chrysanthemum, Atractylodes, and Codonopsis are exported. The ring ratio has decreased. China's major export markets for Chinese herbal medicines and decoction pieces are Asia, and they are concentrated in Hong Kong, Japan, Vietnam, South Korea, and China Taiwan. In the first half of the year, exports to Hong Kong, Germany, and Italy increased rapidly, while exports to Spain, the United Kingdom, and India fell sharply.

In the first half of the year, China’s exports of extracts continued to maintain a growth trend, and for the first time in many years, they occupied the top spot in the export of Chinese herbal medicines. Among them, exports of other vegetable juices and extracts exceeded US$250 million.

China's export market for extracts is mainly the United States and Japan. In the first half of the year, exports to the United States increased by 67%. Due to the impact of the earthquake in Japan, the increase in exports to Japan in the first half of the year was 22.24%, which was lower than the average increase. Demand for natural pigments in the European market increased rapidly at an average rate of 35% per annum. In the first half of the year, China's exports of European extracts increased by 85.55%, of which exports to Germany increased by 133.5%. The demand for emerging markets such as Mexico is also steadily increasing. Export enterprises of extracts in China are mainly concentrated in Shandong, Shanghai, Zhejiang, Jiangsu and Guangdong. In the first half of the year, there were 1,060 export enterprises for extracts, of which 781 were private enterprises, and their exports accounted for 54.24% of the total exports of extracts from China. A year-on-year high growth.

In recent years, the demand for plant extracts has been booming in the international market, and plant-produced products have become new darlings in the fields of health products, foods, beverages, and natural health products. These products have a wide range of uses and large quantities, providing ample space for China's exports. At present, China's planting and picking industry is entering an important transition period after years of development. Whether it can achieve a smooth transition dominated by SMEs led by major companies is a key factor in determining whether the industry can develop healthily in the future.

EU: Chinese medicine export restricted <br> Latin America: health care products, demand for

In the export market, different regions also show different characteristics. Affected by the European Union's “Regulations on Traditional Plant Drug Registration Procedures”, the negative impact of the export of Chinese proprietary Chinese medicines to the EU market began to show; while in Europe and Latin America, the import and export of health products increased significantly.

In the first half of the year, China's exports of proprietary Chinese medicines to the European Union were US$ 8,605,800, an increase of 51.16% year-on-year, mainly due to the fact that some companies from January to April had to complete export transactions before the EU directive took effect. The United Kingdom is the main market for imports of Chinese proprietary Chinese medicine products in the European Union. Before the deadline for the implementation of the directive, British sellers sold a large amount of goods. The above factors have increased the increase in exports of Chinese patent medicines to the EU in the first half of the year. However, from May to June, the impact of the directive on China's exports of proprietary Chinese medicines to the EU began to appear. The value of exports was US$1.7615 million, a year-on-year decrease of 23.69%.

Hong Kong, Japan and the United States of America are still the main export markets for Chinese proprietary Chinese medicines, accounting for about 56% of the total exports of proprietary Chinese medicines. Hong Kong is the area where my Chinese patent medicine exports are most concentrated. The export amount was 47.8477 million US dollars, an increase of approximately 19.78% year-on-year. On the one hand, Hong Kong's local consumer demand for proprietary Chinese medicines is booming. On the other hand, some Hong Kong merchants have branches in the United States and Europe, and Hong Kong has become a transit point for Chinese exports of Chinese proprietary Chinese medicines to the world.

According to statistics of the General Administration of Customs, China's exports of health products in the first half of the year amounted to 98,348,800 US dollars, an increase of 119.4% year-on-year, of which European and Latin American regions experienced rapid growth in demand.

The United States and Japan are my main exporting countries, accounting for 36.84% of China's health products exports. However, in recent years, due to the increasingly stringent Japanese requirements for specific foods for health use, companies have invested more in research and production and have received little revenue, resulting in a slowdown in the growth of Chinese health products exports to Japan. According to statistics, the development of the entire health food market in Japan is not optimistic. According to statistics, the total market volume of Japanese healthy foods has gradually declined since 2005, and it is expected that before 2012, the market will gradually slow down. The recovery of the entire market will be until 2013.

In the first half of this year, due to factors such as Japan's seismic and health products market sluggish consumption, China's exports of Japanese health products were US$7.8019 million, a decrease of 13.61% year-on-year.

In the first half of the year, exports of health products from China were dominated by fish oil, beeswax, lecithin, and royal jelly products. Major export provinces and cities were Guangdong, Zhejiang, Shandong, and Zhejiang, among which exports from Shandong and Henan increased significantly, Hubei and Heilongjiang Regional health products exports have declined significantly.

At present, although the demand for green products in the international market continues to grow, the export of traditional Chinese medicine products will continue to maintain a relatively rapid growth. However, the global economic situation is complex and full of uncertainties, coupled with the frequent occurrence of natural disasters, it may be possible for Chinese medicines. Exports have a certain impact. It is expected that the export of Chinese medicine in the second half of the year will continue to increase, but the growth rate may slow down.